4CJD

Crystal structure of Neisseria meningitidis trimeric autotransporter and vaccine antigen NadA


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.06 Å
  • R-Value Free: 0.207 
  • R-Value Work: 0.182 
  • R-Value Observed: 0.183 

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Structure of the Meningococcal Vaccine Antigen Nada and Epitope Mapping of a Bactericidal Antibody.

Malito, E.Biancucci, M.Faleri, A.Ferlenghi, I.Scarselli, M.Maruggi, G.Lo Surdo, P.Veggi, D.Liguori, A.Santini, L.Bertoldi, I.Petracca, R.Marchi, S.Romagnoli, G.Cartocci, E.Vercellino, I.Savino, S.Spraggon, G.Norais, N.Pizza, M.Rappuoli, R.Masignani, V.Bottomley, M.J.

(2014) Proc Natl Acad Sci U S A 111: 17128

  • DOI: https://doi.org/10.1073/pnas.1419686111
  • Primary Citation of Related Structures:  
    4CJD

  • PubMed Abstract: 

    Serogroup B Neisseria meningitidis (MenB) is a major cause of severe sepsis and invasive meningococcal disease, which is associated with 5-15% mortality and devastating long-term sequelae. Neisserial adhesin A (NadA), a trimeric autotransporter adhesin (TAA) that acts in adhesion to and invasion of host epithelial cells, is one of the three antigens discovered by genome mining that are part of the MenB vaccine that recently was approved by the European Medicines Agency. Here we present the crystal structure of NadA variant 5 at 2 Å resolution and transmission electron microscopy data for NadA variant 3 that is present in the vaccine. The two variants show similar overall topology with a novel TAA fold predominantly composed of trimeric coiled-coils with three protruding wing-like structures that create an unusual N-terminal head domain. Detailed mapping of the binding site of a bactericidal antibody by hydrogen/deuterium exchange MS shows that a protective conformational epitope is located in the head of NadA. These results provide information that is important for elucidating the biological function and vaccine efficacy of NadA.


  • Organizational Affiliation

    Novartis Vaccines, 53100 Siena, Italy; and enrico.malito@novartis.com rino.rappuoli@novartis.com.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
NADA208Neisseria meningitidisMutation(s): 0 
UniProt
Find proteins for A0ELI2 (Neisseria meningitidis serogroup B)
Explore A0ELI2 
Go to UniProtKB:  A0ELI2
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA0ELI2
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.06 Å
  • R-Value Free: 0.207 
  • R-Value Work: 0.182 
  • R-Value Observed: 0.183 
  • Space Group: H 3 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 51.227α = 90
b = 51.227β = 90
c = 577.942γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
XSCALEdata scaling
PHENIXphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2014-11-26
    Type: Initial release
  • Version 1.1: 2014-12-17
    Changes: Database references